<span>Therapeutic cloning means that it could be used to heal people so the best way to benefit the society while doing this would be to help cure diseases. Example would be cloning body parts and testing diseases on them and then developing medication that can help against them. Also you could clone exact body parts that fit you so you could have a new kidney or lungs if necessary that fit you perfectly.</span>
I think the answer is liver and hepatic portal vein
Hope this helps
Answer:
This is a picture of an aminoacid chain
Explanation:
In an amino acid chain all amino acids ( for example GLY, VAL, or ARG) are linked by peptide bonds. Long chains, also called polymers, of amino acids are called proteins. The enlarged photo is an example of a structure of an amino acid. They have an amine (-NH2) and carboxyl (-COOH) functional group, along with a side chain (R group), specific to each amino acid.
Answer:
Thermosensitive liposomes (TSL) are promising tools used to deliver drugs to targeted region when local hyperthermia is applied (∼40–42°C) which triggers the membrane phase transformation from a solid gel-like state to a highly permeable liquid state. Selective lipid components have been used to in TSL formulations to increase plasma stability before hyperthermia and speed drug release rate after. Two generations of TSL technology have been developed. The traditional thermal sensitive liposomes (TTSL) have utilized DPPC and DSPC as a combination. The second generation, lysolipid thermally sensitive liposomes (LTSL) technology, has been developed with incorporation of lysolipids that form stabilized defects at phase transition temperature. LTSL maintains certain favorable attributes:
High percentage of lysolipids incorporation;
Minimum leakage for therapeutical drugs encapsulation;
Ultrafast drug release upon heating (3.5 times enhanced compared to TTSL). For example, ThermoDox, a commonly used LTSL drug for cancer, has been reported to release 100% of the encapsulated doxorubicin within 30s;
First and most successful formulation for intravascular drug release.
Explanation:
https://www.creative-biostructure.com/Lysolipid-Thermally-Sensitive-Liposomes-Production-612.htm
Answer:
90,000 i think if its right your welcome if its not let me know
